Application
BUD13 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the BUD13 antibody detected the BUD13 protein (arrow).Application
BUD13 Antibody (C-term) western blot analysis in mouse kidney tissue lysates (35ug/lane).This demonstrates the BUD13 antibody detected the BUD13 protein (arrow).Application
BUD13 antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the BUD13 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.Application
BUD13 Antibody (C-term) flow cytometric analysis of HepG2 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | BUD13 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | BUD13; BUD13 homolog |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHCFC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | BUD13 BUD13 homolog |
|---|---|
| Molecular Weight(MW) | 70521 Da |
| Tissue Specificity | This BUD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 465-494 amino acids from the C-terminal region of human BUD13. |
| Entrez Gene | 84811 |
|---|---|
| Nucleotide Accession | NP_116114.1 |
Application
BUD13 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the BUD13 antibody detected the BUD13 protein (arrow).
Application
BUD13 Antibody (C-term) western blot analysis in mouse kidney tissue lysates (35ug/lane).This demonstrates the BUD13 antibody detected the BUD13 protein (arrow).
Application
BUD13 antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the BUD13 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Application
BUD13 Antibody (C-term) flow cytometric analysis of HepG2 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
